A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis
Clinical trial NCT05139680 · COMPLETED
Trial details
- NCT number
- NCT05139680
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-08
- Primary completion
- 2023-05-19
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.